Department of Internal Medicine, Division of Infectious Disease, University of Michigan, Ann Arbor, Michigan, USA.
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
mSphere. 2019 Mar 13;4(2):e00126-19. doi: 10.1128/mSphere.00126-19.
Although the microbiota in the proximal gastrointestinal (GI) tract have been implicated in health and disease, much about these microbes remains understudied compared to those in the distal GI tract. This study characterized the microbiota across multiple proximal GI sites over time in healthy individuals. As part of a study of the pharmacokinetics of oral mesalamine administration, healthy, fasted volunteers ( = 8; 10 observation periods total) were orally intubated with a four-lumen catheter with multiple aspiration ports. Samples were taken from stomach, duodenal, and multiple jejunal sites, sampling hourly (≤7 h) to measure mesalamine (administered at = 0), pH, and 16S rRNA gene-based composition. We observed a predominance of across proximal GI sites, with significant variation compared to stool. The microbiota was more similar within individuals over time than between subjects, with the fecal microbiota being unique from that of the small intestine. The stomach and duodenal microbiota displayed highest intraindividual variability compared to jejunal sites, which were more stable across time. We observed significant correlations in the duodenal microbial composition with changes in pH; linear mixed models identified positive correlations with multiple operational taxonomic units (OTUs) and negative correlations with multiple and OTUs. Few OTUs correlated with mesalamine concentration. The stomach and duodenal microbiota exhibited greater compositional dynamics than the jejunum. Short-term fluctuations in the duodenal microbiota were correlated with pH. Given the unique characteristics and dynamics of the proximal GI tract microbiota, it is important to consider these local environments in health and disease states. The gut microbiota are linked to a variety of gastrointestinal diseases, including inflammatory bowel disease. Despite this importance, microbiota dynamics in the upper gastrointestinal tract are understudied. Our article seeks to understand what factors impact microbiota dynamics in the healthy human upper gut. We found that the upper gastrointestinal tract contains consistently prevalent bacterial OTUs that dominate the overall community. Microbiota variability is highest in the stomach and duodenum and correlates with pH.
尽管近端胃肠道 (GI) 中的微生物群与健康和疾病有关,但与远端 GI 中的微生物群相比,人们对这些微生物群的了解还很有限。本研究旨在描述健康个体中近端 GI 多个部位随时间变化的微生物群。作为口服美沙拉嗪药代动力学研究的一部分,健康、禁食志愿者( = 8;共 10 个观察期)通过带有多个抽吸端口的四腔导管经口插管。从胃、十二指肠和多个空肠部位采集样本,每小时(≤7 小时)采集一次以测量美沙拉嗪(在 = 0 时给予)、pH 值和基于 16S rRNA 基因的组成。我们观察到近端 GI 部位的 占主导地位,与粪便相比存在显著差异。微生物群在个体内随时间的变化比在个体间更相似,粪便微生物群与小肠的微生物群不同。与空肠部位相比,胃和十二指肠的微生物群显示出更高的个体内变异性,而空肠部位在整个时间内更稳定。我们观察到十二指肠微生物组成与 pH 值变化之间存在显著相关性;线性混合模型确定了与多个 操作分类单位 (OTU) 呈正相关,与多个 和 OTU 呈负相关。很少有 OTU 与美沙拉嗪浓度相关。胃和十二指肠的微生物群比空肠表现出更大的组成动态。十二指肠微生物群的短期波动与 pH 值相关。鉴于近端 GI 微生物群的独特特征和动态,在健康和疾病状态下考虑这些局部环境非常重要。肠道微生物群与多种胃肠道疾病有关,包括炎症性肠病。尽管如此,上消化道的微生物群动态研究还很有限。我们的文章旨在了解哪些因素影响健康人体上消化道的微生物群动态。我们发现,上消化道包含一致存在的优势细菌 OTU,这些 OTU主导着整个群落。胃和十二指肠中的微生物群变异性最高,与 pH 值相关。